When your time comes, your treatment may not – findings from new Canadian survey data

In these unprecedented times, access to new medicines and vaccines has never been more important. However, new federal regulations to limit the prices of medicines and vaccines are hurting Canadians’ access to new life-saving medicines and doing irreparable harm to Canada’s life sciences sector, which has been at the forefront of Canada’s response to the COVID-19 crisis.

Join Dr. Jason Field (Life Sciences Ontario), Mike Colledge (Ipsos Canada), Rachelle Deshaies (Research Etc Inc.), and Jennifer Chan (Merck Canada) for a discussion on new Canadian research data which reviews public opinion and pharmaceutical leader perspectives on access to medicines, price regulation and health innovation.

Two short presentations, a panel discussion and Qs and As with webinar participants will contribute to a growing body of research that shows how new federal price controls are forcing pharmaceutical companies to delay or not bring new medicines and vaccines to Canada.